The Indian pharmaceutical industry has witnessed an upsurge in business in the past decade and PCD pharma franchise in India are one of the trendy business models that have enhanced business growth. Many of the entrepreneurs will fail to create viable businesses, despite coming to this industry with the hope that they can make a quick buck.
It is not just the capability of establishing monopoly rights or the low-level investment that makes the difference between the success of PCD pharma businesses and the failure of product range and product quality. The two play a central role in giving the doctor confidence, penetrating the market, making repeat purchases, and having a long-term brand image. This blog supports the rationale behind the fact that product portfolio depth and consistent quality are the true foundations of PCD pharma success.
PCD (Propaganda Cum Distribution) pharma franchise is an opportunity provided to individuals or at least distributors so as to promote and market the pharmaceuticals of a firm in a given region. In most cases the franchise partners are given monopoly rights. Therefore, there will be no other distributor of the same company in the same region.
The reasons behind the popularity of the PCD model in India are:
Low initial investment
Great demand for inexpensive medicine.
Preaching more medical attention in the semi-urban and rural regions.
It has also created increased interest in investing in monopoly PCD pharma franchises especially for those who have never ventured into pharma ventures before.
Product range refers to the number of medicines that a given company possesses concerning dosage forms and therapeutic segments. They are tablets, capsules, syrups, injections, ointments, and nutraceuticals.
The high product portfolio would allow distributors to:
Cater to a number of physicians and specialties.
Improve average order value.
Decrease the dependence on a single expeditious product.
The doctors would prefer to handle the distributors that would provide most of their orders through one company.
The performance of some of the segments is robust across Indian markets:
Antibiotics
Gastrointestinal medicines
Pain management
Nutraceuticals and vitamins.
Antibiotics franchise in India has been considered as one of the most constant and high-volume segments because the prescription of antibiotics is done throughout the year and by all ages and medical specialties.
The doors are opened with the help of the product range, yet they are maintained in open state with the product's quality.
Quality is determined by:
WHO certified and GMP production.
Proper formulation and dosage.
Stability of shelf life and safe packaging.
The majority of the new franchise partners are getting into the trap of either:
A general-purpose firm of doughty quality, or
A company with high-quality and very cheap products.
The two methods limit growth.
Sustainable PCD has been made possible because of:
The differentiated and focused product line.
Equal quality of products.
Added relevant molecules continuously.
Inability to grow due to lack of variety in quality and inability to fail due to lack of quality in variety lead to short-term profit and long-term failure respectively.
Third party pharma manufacturing is a situation where a company hires a plant to produce its products as opposed to producing them in-house. It is an Indian model that is popular.
The third-party manufacturing allows the pharma companies to:
Launch new products faster.
Reduce infrastructure and production costs.
Offer competitive pricing.
This is not too rigid to enable PCD companies to develop larger portfolios without cutting margins.
Quality depends on:
Application of manufacturing partners that are GMO-compliant.
Audits on quality and batch testing.
Transparent documentation
Antibiotics remain one of the most needed pharmaceuticals.
Antibiotics are applied in the treatment of:
Respiratory infections
Gastrointestinal infections
Infection of the urinary tract and skin infection.
This makes them a requirement in the collection of all distributors.
As the problems of antibiotic resistance grow, doctors prefer brands that are controlled in terms of high quality. In India, a reputable franchise of antibiotics helps the distributor to have easier acceptance and the repetition of prescription.
Right to distributors: A distributor is awarded a monopoly to execute marketing to a specific predominant area and this reduces internal competition.
Better pricing authority
Greater distributor component.
Clear market positioning
However, it is not a guarantee of success because it is a monopoly. Discrimination cannot be valued in any way unless there are good products and frequent quality.
Prior to their choice of a franchise partner, entrepreneurs would have to be requested to answer:
What is the length and size of the product range?
Are GMP and DCGI compliant with the products?
Does it have transparency with third parties in manufacturing?
Do the rights to monopolies exist and are they registered?
The companies that are engaging in the low pricing without demonstrating quality or even regulation should not be used.
To those entrepreneurs who require a reliable business partner who has a good product portfolio, quality assurances, PCD pharma franchise in India, third party pharma manufacturing, antibiotics franchise India, and real monopoly PCD pharma franchise opportunities, Iscon Life Sciences Pvt. Ltd. is a preferred business partner that believes in sustainable growth in the competitive Indian pharma market.
Your email address will not be published. Required fields are marked *
